Dermatology

Skin cancer checks, eczema/psoriasis, acne care, and cosmetic dermatology news.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Dermatology


thespec.com > globenewswire > oncolytics-biotech-secures-patent-protection-to-late-2040s-and-provides-intellectual-property-portfolio-update > article_4b1e827f-4958-546d-b55c-1b64d19f569f.html

Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update

1+ hour, 36+ min ago   (123+ words) New method of use patent covering pelareorep as an immunotherapy for cancer has been issued in several countries, with U.S. issuance expected in the near term Three patent applications are pending, including two method of use with one expected to be…...


managedhealthcareexecutive.com > view > chronic-hand-eczema-needs-more-than-topical-steroids-fall-clinical-derm-2026

Chronic hand eczema needs more than topical steroids | Fall Clinical Derm 2026

12+ min ago   (278+ words) Topical steroids remain first-line for chronic hand eczema, but long-term use can thin the skin and leave patients with poorly controlled disease. Topical corticosteroids remain a reasonable first-line treatment for chronic hand eczema, but they are poorly suited to the…...


managedhealthcareexecutive.com > view > melanoma-care-is-shifting-to-risk-based-screening-and-treatment-before-surgery-fall-clinical-derm-2026

Melanoma care is shifting to risk-based screening and treatment before surgery | Fall Clinical Derm 2026

12+ min ago   (381+ words) Broad skin cancer screening may not be the best use of clinicians' time, and more patients with melanoma are getting immunotherapy before surgery, according to Laura Ferris, M.D., Ph.D., professor and chair of the department of dermatology at the University of…...


newbeauty.com > view > eczema-skin-care

The Next Era of Eczema

1+ hour, 36+ min ago   (755+ words) Eczema care is getting a beauty makeover, landing at retailers like Sephora. What does that mean for the more than 32 million Americans living with it? Eczema has spent most of its existence being decidedly unglamorous. Now, the inflammatory disease—marked…...


managedhealthcareexecutive.com > view > choosing-first-biologic-for-hs-as-recommended-jennifer-hsiao-m-d-fall-clinical-derm-2026

Choosing a first biologic for HS, as recommended by Jennifer Hsiao, M.D. | Fall Clinical Derm 2026

1+ hour, 2+ min ago   (290+ words) With three FDA-approved biologics for hidradenitis suppurativa, Jennifer Hsiao, M.D., said patient preference and access often decide which comes first. Dermatologists treating hidradenitis suppurativa (HS) now have three FDA-approved biologics to choose from. Deciding which one to start tends to come…...


managedhealthcareexecutive.com > view > jenny-hsiao-says-hs-biologics-need-time-to-work-fall-clinical-derm-2026

Jenny Hsiao, M.D., says HS biologics need time to work | Fall Clinical Derm 2026

1+ hour, 3+ min ago   (401+ words) Patients with HS should get three to four months on a biologic before a switch, says a dermatologist who sees promise in oral JAK inhibitors. Patients starting a biologic for hidradenitis suppurativa (HS) need to know up front that results…...


ajmc.com > view > consensus-sets-biopsy-discontinuation-rules-for-dupilumab-linked-ctcl

Consensus Helps Dermatologists Spot CTCL Mimicking Atopic Dermatitis on Dupilumab

1+ hour, 23+ min ago   (357+ words) Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches. Atopic dermatitis and early-stage cutaneous T-cell lymphoma (CTCL) can look identical on the skin, and dupilumab (Dupixent;…...


ajmc.com > view > early-hs-treatment-may-prevent-scarring-in-patients-with-skin-of-color

Early HS Treatment May Prevent Scarring in Patients With Skin of Color

1+ hour, 24+ min ago   (171+ words) Hidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place. “Obesity is not the reason for HS. It is a part of your HS, and HS is not…...


dermatologytimes.com > view > nonmelanoma-skin-cancer-beyond-surgery-pdt-immunotherapy-and-pipeline-agents

Nonmelanoma Skin Cancer Beyond Surgery: PDT, Immunotherapy, and Pipeline Agents

1+ hour, 23+ min ago   (178+ words) Adjuvant cemiplimab (Libtayo; Regeneron) is an option after surgery and radiation for patients with locally advanced squamous cell carcinoma and high-risk features. Schlesinger cited perineural invasion, multiple lymph nodes, and deep tumor invasion as examples. He called the adjuvant approach…...


dermatologytimes.com > view > fda-approves-ruxolitinib-cream-1-5-to-treat-nonsegmental-vitiligo

FDA Approves Ruxolitinib Cream 1.5% to Treat Nonsegmental Vitiligo

1+ hour, 28+ min ago   (412+ words) Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights....